Independent Risk Factors for "Deaths of Despair" Found.

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

AACR: American Association for Cancer Research

CAR-T Trial Raises Prospect of Preventing Myeloma in High-Risk Group

All 20 smoldering myeloma patients had deep responses after one-time infusion

Next-Generation KRAS G12C Inhibitor Shows 'Robust' Efficacy in Advanced Lung Cancer

Responses observed in patients with and without previous exposure to other KRAS G12C inhibitors

Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions

Approach could help patients avoid often debilitating surgeries, early study suggests

Study Linking Fruits, Veggies to Lung Cancer Raises Eyebrows

Association by way of pesticide exposure proposed, but outside experts not so sure

More Positive Survival Data in Lung Cancer With Perioperative Therapy

High rate of tumor DNA clearance with chemoimmunotherapy portends improved EFS, possibly OS

SCOTUS Grapples With Multibillion-Dollar Lawsuits Over Roundup Cancer Claims

Several justices seemed sympathetic to Monsanto's argument that it can't be sued under state law

Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer

News, features, and commentary about cancer-related issues

FDA Says First 'Real-Time' Clinical Trial Is Underway

Two sponsors are on board, with a larger pilot program planned later this year

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven

However, rates were improved from previous survey results

Pooled Cord Blood Transplants Achieve Near-Perfect Results in Early Trial

Disease-free survival of 96% with no severe GVHD in acute leukemia, other blood cancers

Novel Mimetic Bispecific Antibody Superior to Standard Care in Hemophilia A

Mim8 prophylaxis significantly reduced bleeding events in patients with or without inhibitors

High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy

Three-fourths of patients had cancer-free mediastinal lymph nodes, clear surgical margins in 93%

J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79

His death followed a hospitalization for cancer treatment side effects

Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey

News, features, and commentary about cancer-related issues